FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2137215641> ?p ?o ?g. }

• W2137215641 endingPage "682" @default.
• W2137215641 startingPage "675" @default.
• W2137215641 abstract "Proton pump inhibitors (PPIs) are among the most prescribed medications worldwide, however, there is growing concern regarding potential negative effects on bone health. The aim was to examine the effect of dose and type of PPI use on subsequent use of osteoporosis medication and fractures in older Australian women. Data were included from 4432 participants (born 1921–26) in the 2002 survey of the Australian Longitudinal Study on Women's Health. Medication data were from the national pharmaceutical administrative database (2003–2012, inclusive). Fractures were sourced from linked hospital datasets available for four major States of Australia. Competing risk regression models used PPI exposure as a time-dependent covariate and either time to first osteoporosis medication prescription or fracture as the outcome, with death as a competing risk. Of the 2328 PPI users and 2104 PPI non-users, 827 (36%) and 550 (26%) became users of osteoporosis medication, respectively. PPI use was associated with an increased risk of subsequent use of osteoporosis medication (adjusted sub-hazard ratio [SHR] = 1.28; 95% confidence interval [CI] = 1.13–1.44) and subsequent fracture (SHR = 1.29, CI = 1.08–1.55). Analysis with PPI categorized according to defined daily dose (DDD), showed some evidence for a dose–response effect (osteoporosis medication: <400 DDD: SHR = 1.23, CI = 1.06–1.42 and ≥400 DDD: SHR = 1.39, CI = 1.17–1.65, compared with non-users; SHRs were in the same range for fractures). Esomeprazole was the most common PPI prescribed (22.9%). Analysis by type of PPI use showed an increased subsequent risk for: (1) use of osteoporosis medication for rabeprazole (SHR = 1.51, CI = 1.08–2.10) and esomeprazole (SHR = 1.48, CI = 1.17–1.88); and (2) fractures for rabeprazole (SHR = 2.06, CI = 1.37–3.10). Users of multiple types of PPI also had increased risks for use of osteoporosis medication and fractures. An appropriate benefit/risk assessment should be made when prescribing PPIs, especially for esomeprazole and rabeprazole, as osteoporosis and fracture risks were increased in this cohort of elderly females subsequent to PPI prescription." @default.
• W2137215641 created "2016-06-24" @default.
• W2137215641 creator A5014120000 @default.
• W2137215641 creator A5037983586 @default.
• W2137215641 creator A5065050599 @default.
• W2137215641 creator A5080377694 @default.
• W2137215641 creator A5083659255 @default.
• W2137215641 date "2015-12-01" @default.
• W2137215641 modified "2023-10-18" @default.
• W2137215641 title "The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study" @default.
• W2137215641 cites W125279441 @default.
• W2137215641 cites W1525757091 @default.
• W2137215641 cites W1575300168 @default.
• W2137215641 cites W1967618574 @default.
• W2137215641 cites W1974737882 @default.
• W2137215641 cites W1989031798 @default.
• W2137215641 cites W2002929828 @default.
• W2137215641 cites W2003999361 @default.
• W2137215641 cites W2004440549 @default.
• W2137215641 cites W2004509444 @default.
• W2137215641 cites W2004626852 @default.
• W2137215641 cites W2012514506 @default.
• W2137215641 cites W2016163945 @default.
• W2137215641 cites W2020732194 @default.
• W2137215641 cites W2023841540 @default.
• W2137215641 cites W2026656096 @default.
• W2137215641 cites W2029569451 @default.
• W2137215641 cites W2031212518 @default.
• W2137215641 cites W2043300094 @default.
• W2137215641 cites W2045552475 @default.
• W2137215641 cites W2067061442 @default.
• W2137215641 cites W2068167747 @default.
• W2137215641 cites W2071521423 @default.
• W2137215641 cites W2079974164 @default.
• W2137215641 cites W2082010609 @default.
• W2137215641 cites W2085498457 @default.
• W2137215641 cites W2102395823 @default.
• W2137215641 cites W2105487064 @default.
• W2137215641 cites W2111714917 @default.
• W2137215641 cites W2117874992 @default.
• W2137215641 cites W2121233227 @default.
• W2137215641 cites W2123564870 @default.
• W2137215641 cites W2128573777 @default.
• W2137215641 cites W2139871454 @default.
• W2137215641 cites W2143121646 @default.
• W2137215641 cites W2148792541 @default.
• W2137215641 cites W2156899992 @default.
• W2137215641 cites W2254476945 @default.
• W2137215641 cites W3207101724 @default.
• W2137215641 cites W405926290 @default.
• W2137215641 cites W4292806894 @default.
• W2137215641 doi "https://doi.org/10.1016/j.bone.2015.08.024" @default.
• W2137215641 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26319499" @default.
• W2137215641 hasPublicationYear "2015" @default.
• W2137215641 type Work @default.
• W2137215641 sameAs 2137215641 @default.
• W2137215641 citedByCount "52" @default.
• W2137215641 countsByYear W21372156412014 @default.
• W2137215641 countsByYear W21372156412015 @default.
• W2137215641 countsByYear W21372156412016 @default.
• W2137215641 countsByYear W21372156412017 @default.
• W2137215641 countsByYear W21372156412018 @default.
• W2137215641 countsByYear W21372156412019 @default.
• W2137215641 countsByYear W21372156412020 @default.
• W2137215641 countsByYear W21372156412021 @default.
• W2137215641 countsByYear W21372156412022 @default.
• W2137215641 crossrefType "journal-article" @default.
• W2137215641 hasAuthorship W2137215641A5014120000 @default.
• W2137215641 hasAuthorship W2137215641A5037983586 @default.
• W2137215641 hasAuthorship W2137215641A5065050599 @default.
• W2137215641 hasAuthorship W2137215641A5080377694 @default.
• W2137215641 hasAuthorship W2137215641A5083659255 @default.
• W2137215641 hasConcept C126322002 @default.
• W2137215641 hasConcept C188816634 @default.
• W2137215641 hasConcept C201903717 @default.
• W2137215641 hasConcept C207103383 @default.
• W2137215641 hasConcept C23276603 @default.
• W2137215641 hasConcept C2426938 @default.
• W2137215641 hasConcept C2776541429 @default.
• W2137215641 hasConcept C2777251235 @default.
• W2137215641 hasConcept C2778204628 @default.
• W2137215641 hasConcept C2778885795 @default.
• W2137215641 hasConcept C2781025758 @default.
• W2137215641 hasConcept C44249647 @default.
• W2137215641 hasConcept C71924100 @default.
• W2137215641 hasConcept C98274493 @default.
• W2137215641 hasConceptScore W2137215641C126322002 @default.
• W2137215641 hasConceptScore W2137215641C188816634 @default.
• W2137215641 hasConceptScore W2137215641C201903717 @default.
• W2137215641 hasConceptScore W2137215641C207103383 @default.
• W2137215641 hasConceptScore W2137215641C23276603 @default.
• W2137215641 hasConceptScore W2137215641C2426938 @default.
• W2137215641 hasConceptScore W2137215641C2776541429 @default.
• W2137215641 hasConceptScore W2137215641C2777251235 @default.
• W2137215641 hasConceptScore W2137215641C2778204628 @default.
• W2137215641 hasConceptScore W2137215641C2778885795 @default.
• W2137215641 hasConceptScore W2137215641C2781025758 @default.
• W2137215641 hasConceptScore W2137215641C44249647 @default.

• next